Product Information
GEMFIBROZIL 600 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1045 per EA under NDC 16571078406. Its NADAC has been published 242 times since Jan 5, 2022.
FDA first approved this application on Sep 16, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078406
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GEMFIBROZILApproval Type
Generic (ANDA)
FDA Application
ANDA202726FDA Approved
9/16/2015
TE Code
AB
On Market Since
9/16/2015
Pharmacological Classes
Price Statistics
The NADAC for GEMFIBROZIL 600 MG TABLET has been published 242 times since Jan 5, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1045 per EA |
|---|---|
| All-time high | $0.1135 (Feb 14, 2024) |
| All-time low | $0.0871 (Nov 20, 2024) |
| 52-week high | $0.1045 |
| 52-week low | $0.1005 |
| Median price | $0.1043 |
| Average price | $0.1038 |
| Largest weekly change | -18.6% (Apr 17, 2024) |
| Weeks tracked | 242 |
| Tracking since | Jan 5, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GEMFIBROZIL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1045 per EA (NDC 16571078406), effective Aug 19, 2026.
How has the price of GEMFIBROZIL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has held within roughly two percent of its current level. It has been tracked across 242 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?
Since Jan 5, 2022, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0871 (Nov 20, 2024) to a high of $0.1135 (Feb 14, 2024), with a median of $0.1043 per EA.
Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 15% below GEMFIBROZIL 600 MG TABLET.
Who manufactures GEMFIBROZIL 600 MG TABLET?
GEMFIBROZIL 600 MG TABLET (NDC 16571078406) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.